Skip to main content
Premium Trial:

Request an Annual Quote

Miraculins Offers up to $470K in Placement

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Canadian diagnostics developer Miraculins aims to gain up to C$500,500 ($469,200) in gross proceeds through a private placement of as many as 7,150,000 units priced at C$.07 per unit.

The firm, which trades on the TSX Venture Exchange, said on Tuesday that it plans to use the proceeds from the placement for research and development and for corporate working capital.

The units in the placement will include one common share and one share purchase warrant, priced at C$.10. The warrants will be callable by the company if the share price rises above C$.14 for any 20 out of 30 consecutive trading days.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.